CCHR International CCHR, concerned that children face motor skill failure, psychosis, suicide, memory loss and brain damage side effects from mental health therapies, refutes $82.5m of taxpayer dollars being invested in early-intervention research that may add harm. The U.S. National Institutes of Health (NIH) has granted $33 million to an Australian youth mental health research program that … Read more
CCHR says new UK research on electroshock “therapy” damage—given each year to 100,000 Americans, including children as young as five—should prompt review of U.S. studies and a ban on the practice. Citizens Commission on Human Rights International, a mental health industry watchdog, praised new UK peer-reviewed research published in the journal Ethical Human Psychology and … Read more
A Central Intelligence Agency (CIA) document dated 3 December 1951 described the use of subconvulsive electroshock as having the effect of “making a man talk.” An unnamed psychiatrist quoted in the CIA document stated that the lower setting of the device “produced in the individual excruciating pain and that the individual would be quite willing … Read more
How did electroshock, with no history of having done anybody any good, venture into countries like the United States and United Kingdom with “authoritative” recognition? How was it that it continued to be used, despite its link to Nazi atrocities? In a 1992 paper, “The Introduction and Spread of Shock and the Emigration of Psychiatrists,” … Read more
A new book published in February 2019 claimed that famed actress, Vivien Leigh who starred in Gone with the Wind (1939) and A Street Car Named Desire (1951) had suffered from bipolar disorder.[1] However, Leigh, along with many other artists, were victims of psychiatric treatment, especially electroconvulsive therapy (electroshock, ECT) that not only failed but … Read more
Excerpted from CCHR’s submission to the FDA opposing its 2015 proposal to reclassify the ECT device as a Class II low risk device. CCHR’s submission was submitted in March 2016. In May 2006, Harold Robertson and Robin Pryor writing in BJPsych, “Memory and cognitive effects of ECT: informing and assessing patients,” determined: “Data do not … Read more
Excerpted from CCHR’s submission to the FDA opposing its 2015 proposal to reclassify the ECT device as a Class II low risk device. CCHR’s submission was submitted in March 2016. It is clear that the Food and Drug Administration (FDA) and American Psychiatric Association (APA) members know that the ECT device manufacturers are not going … Read more
Excerpted from CCHR’s submission to the FDA opposing its 2015 proposal to reclassify the ECT device as a Class II low risk device. CCHR’s submission was submitted in March 2016. The U.S. Food and Drug Administration (FDA) undermines the scores of studies and patient testimonies that indicate ECT causes brain damage. Dr. Lawrence Park, the … Read more
Excerpted from CCHR’s submission to the FDA opposing its 2015 proposal to reclassify the ECT device as a Class II low risk device. CCHR’s submission was submitted in March 2016. In 2013, Kathleen Lynch, Minister of State for Disability, Equality, Mental Health and Older People in Ireland stated that Ireland’s mental health law “will be … Read more
Excerpted from CCHR’s submission to the FDA opposing its 2015 proposal to reclassify the ECT device as a Class II low risk device. CCHR’s submission was submitted in March 2016. The Food and Drug Administration (FDA) Proposal in 2015 to reduce the risk classification of the ECT device instead of banning it, is of enormous … Read more